Arrowstreet Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.3M | Buy |
4,278,555
+4,084,403
| +2,104% | +$36.6M | 0.03% | 494 |
|
|
2025
Q1 | $1.46M | Sell |
194,152
-209,260
| -52% | -$1.57M | ﹤0.01% | 1388 |
|
|
2024
Q4 | $3.03M | Sell |
403,412
-27,818
| -6% | -$209K | ﹤0.01% | 1162 |
|
|
2024
Q3 | $3.28M | Buy |
+431,230
| New | +$3.28M | ﹤0.01% | 1096 |
|
|
2014
Q3 | – | Sell |
-36,011
| Closed | -$459K | – | 985 |
|
|
2014
Q2 | $459K | Buy |
+36,011
| New | +$459K | ﹤0.01% | 840 |
|